Skyepharma Production SAS is a specialist CDMO with particular expertise and capabilities in oral solid dosage forms, being a key player in drug development and delivery of oral technologies serving the global pharmaceutical, biotech and consumer health industries. As an integrated CDMO, Skyepharma’s controlled-release technologies and oral solids products offer solution for development, manufacturing and packaging of classic and complex oral solid dosage forms, including single layer tablets, multi-layer tablets, tab-in-tab, tab-in-caps, hard gel capsules and sachets.